« Return to News | Study Conduct

SCRS launches Global Impact Partnership Program

Friday, June 21, 2013 10:35 AM

The Society for Clinical Research Sites (SCRS) has launched the Global Impact Partnership (GIP) Program. In just over one month, 12 organizations have joined as partners to provide ongoing development, feedback and support of industry initiatives designed to include and improve the voice of clinical research sites. 

The GIP board will work in tandem with SCRS’ Leadership Council to identify the work streams most significant to the success of research sites across the world.  Each GIP member will appoint one executive level team member to represent its organization, and each organization has made a two year commitment to SCRS. 

The founding GIP industry partners include: Amgen, AstraZeneca, Eli Lilly, PPD and Roche.GIP professional partners include: Acurian, Aspire IRB, Bio-Optronics, CFS Clinical, Clinical Site Services, DAC Patient Recruitment Services and ePharmaSolutions.

The GIP board will work toward industry changes, from operational management to contracts, to subject retention and more. The collaboration with SCRS will continue throughout the year.

"The response our community of sites has received from industry has affirmed that the mission of SCRS to represent the global site community and ensure our voice is heard was long overdue, and they want to be a part of the advancement of SCRS,” said SCRS president Christine Pierre.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.